Acyclovir Pharmacology
Acyclovir is an antiviral agent highly active in vitro against herpes simplex virus (HSV) types I and II, and varicella zoster virus. Upon entry into the infected cell, the phosphorylated form of the active compound Acyclovir Acyclovir trifosfate. The initial phase of the process depends on the enzyme thymidine kinase viral-coded. Acyclovir trifosfate act as inhibitors and as a false substrate for the herpes-specified DNA polymerase which prevents viral DNA synthesis without affecting normal cellular processes.
Treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes / recurrent, herpes zoster (shingles / shingles / shingles). Preventing recurrence of herpes simplex infections in patients with strong immune systems. Preventing herpes simplex infection in patients with poor immune systems.
Another acyclovir pharmacology is a treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes / recurrent, herpes zoster (shingles / shingles / shingles); preventing recurrence of herpes simplex infections in patients with strong immune systems; preventing herpes simplex infection in patients with poor immune systems.
Acyclovir Indication
Acyclovir indication such as treatment of herpes simplex virus on the skin and mucus membranes, including initial and recurrent genital herpes; treatment of herpes zoster and varicella infections; treatment of infections caused by the herpes simplex of the skin and mucous membranes including initial and recurrent genital herpes, herpes simplex infection prevention in immuno-compromised patients; treatment of herpes zoster infection.
